| # | Drug | Count |
|---|---|---|
| 0 | ABIRATERONE ACETATE | 3 |
| 1 | DOCETAXEL | 3 |
| 2 | DOCETAXEL ANHYDROUS | 3 |
| 3 | ENZALUTAMIDE | 3 |
| 4 | ABIRATERONE | 2 |
| 5 | AMITRIPTYLINE HYDROCHLORIDE | 2 |
| 6 | CABAZITAXEL | 2 |
| 7 | CARBOPLATIN | 2 |
| 8 | CYCLOPHOSPHAMIDE | 2 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABAZITAXEL | 2 | 0.0006 |
| 1 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 2 | AMITRIPTYLINE HYDROCHLORIDE | 2 | 0.0001 |
| 3 | ABIRATERONE ACETATE | 3 | 0.0001 |
| 4 | BICALUTAMIDE | 1 | 0.0001 |
| 5 | ENZALUTAMIDE | 3 | 0.0001 |
| 6 | HYDROXYUREA | 1 | 0.0000 |
| 7 | DOCETAXEL | 3 | 0.0000 |
| 8 | DOCETAXEL ANHYDROUS | 3 | 0.0000 |
| 9 | IBRUTINIB | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 4 |
| 1 | Microtubule Inhibitor [EPC] | 3 |
| 2 | Alkylating Drug [EPC] | 2 |
| 3 | Kinase Inhibitor [EPC] | 2 |
| 4 | Platinum-based Drug [EPC] | 2 |
| 5 | Thalidomide Analog [EPC] | 2 |
| 6 | Antimetabolite [EPC] | 1 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 4 | Thalidomide Analog [EPC] | 2 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |